Interested in Connecting? Please contact:
Dr. Maggie Lu
General Manager
maggie@metagone.com.tw

Message the company or request a 1:1 meeting here

Metagone devote his mind to novel targets and early stage discovery. The innovation with unique targets-pDAPK, MAP3K19, Meta1, which can be used as a drug target and original molecule design on first-in-class. This is the core of precision medicine allowing more effective therapy for anti-cancer and respiratory diseases. Expect Metagone’s new medicine has therapeutic advantages and global market.

Pitch Video